Skip to main content

Texas Instruments: Analysts' Upgrades, Downgrades

Texas Instruments estimates increased at UBS through 2011. Company boosted guidance in its mid-quarter update.
  • Author:
  • Publish date:



) --


Alpha & Omega Semiconductor Limited


initiated at Thomas Weisel with an Overweight rating and $20 price target. AOSL has shown rapid growth recently through market share gains and an intense focus on the Asian consumer electronics.



rated new Buy at ThinkEquity. $94 price target. Company is a market leader and new technology is driving accelerated growth.

Choice Hotels


upgraded at JP Morgan. Rating raised to Neutral from Underweight. Maintains $31 price target and 2010 EPS estimates of $1.75.



initiated at Thomas Weisel with an Overweight rating and $13 price target. Pure play way to capture non-profit shift to online giving.

Scroll to Continue

TheStreet Recommends



upgraded at Citigroup from Hold to Buy. $110 price target. Domestic revenue growth should improve in the second half of the year.



rated new Perform at Oppenheimer. Do not expect carbon pricing or a near-term recovery in gas prices to cause a shift toward nuclear.

F5 Networks


downgraded at Ticonderoga from Buy to Neutral. Company could be hurt by potential changes in the enterprise spending environment.

Jones Apparel


reinstated as Neutral at Goldman. $19 price target. Estimates also lowered, because of coast inflation.

Allscripts-Misys Healthcare Solutions


upgraded at Thomas Weisel to Overweight from Market Weight on improved near and long-term outlook. Price target jumped to $24 from $20.



upgraded at Roth to Buy. Stock has lost 30% since March, and is now valued at just 2 times sales.

PAA Natural Gas Storage


initiated at BofA/Merrill with a Neutral rating and $25.50 price target. Growth story reflected in valuation.



upgraded at UBS. POT was upgraded from Neutral to Buy. $112 price target. Company should see higher potash production in 2011.



upgraded at UBS from Neutral to Buy. $32 price target. Risk/reward is compelling, following the recent pullback.


Best Buy


price target lowered at BofA/Merrill to $44 from $50 ahead of 1Q results, which will be released on Tuesday, June 15. Maintain Neutral rating.

Boston Scientific


cut from Conviction Sell List at Goldman. Stock is down 21% since March, and approaching the $5.50 price target.

Dollar General


price target higher at Barclays. DG price target jumped to $34 from $29 as the company is reaping benefits from its initiatives. Also, DG is being offered lots of great sites at good prices. Maintain Overweight rating.

Dick's Sporting Goods


added to Top Picks Live at Citi. Company should continue to take market share, especially from TSA.

Endo Pharmaceuticals


estimates upped at Goldman through 2013. Opana ER received extended exclusivity. Buy rating and $27 price target.

Monster Worldwide


added to Focus List at MKM Partners. Stock is already pricing in the potential for a double-dip and margins have likely bottomed.

Norfolk Southern


price target higher at Barclays: to $65 from $62 on volume strength and solid price fundamentals. Estimates raised through 2011. Maintain Overweight rating.

Time Warner Cable


price target jumped at Barclays to $55 from $46 given overall sector multiple expansion. 2010 and 2011 EPS estimates tweaked lower to $3.28 and $3.93, respectively. Equal Weight rating.

Texas Instruments


estimates increased at UBS through 2011. Company boosted guidance in its mid-quarter update. Neutral rating and $25 price target.

Union Pacific Corp


price target tweaked lower at Barclays to $83 from $85 based on reduced buyback assumptions. Maintain Equal Weight rating.

Westlake Corp


price target lower at Barclays. WLK price target trimmed to $17 from $19 as prices and profit margins in the U.S. plastic markets have weakened quickly. Reiterate Underweight rating.

This article was written by a staff member of